NCT01526876View on ClinicalTrials.gov

The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

December 19, 2012

Conditions

Hypertension

Interventions

DRUG

clevidipine butyrate

intravenous infusion dose range 1.0 mg/hr - 32 mg/hr titrate to blood pressure effect duration of infusion: 6 hours

Sponsors

Collaborators (1)

The Medicines Company

All Listed Sponsors

collaborator

The Medicines Company

INDUSTRY

lead

Columbia University

OTHER